CANCER:

Chronic Neutrophilic Leukemia

Related cancers:

‹

Leukemia (1625)

Acute Myelogenous Leukemia (726)

Acute Lymphocytic Leukemia (331)

Chronic Myeloid Leukemia (255)

Chronic Lymphocytic Leukemia (243)

B Acute Lymphoblastic Leukemia (128)

T Acute Lymphoblastic Leukemia (36)

Childhood B Acute Lymphoblastic Leukemia (35)

Hairy Cell Leukemia (16)

Chronic Myelomonocytic Leukemia (15)

Prolymphocytic Leukemia (12)

Acute Promyelocytic Leukemia (10)

Chronic Eosinophilic Leukemia (4)

Juvenile Myelomonocytic Leukemia (3)

Leukemia (1625)

Acute Myelogenous Leukemia (726)

Acute Lymphocytic Leukemia (331)

Chronic Myeloid Leukemia (255)

Chronic Lymphocytic Leukemia (243)

B Acute Lymphoblastic Leukemia (128)

T Acute Lymphoblastic Leukemia (36)

Childhood B Acute Lymphoblastic Leukemia (35)

Hairy Cell Leukemia (16)

Chronic Myelomonocytic Leukemia (15)

Prolymphocytic Leukemia (12)

Acute Promyelocytic Leukemia (10)

Chronic Eosinophilic Leukemia (4)

Juvenile Myelomonocytic Leukemia (3)

›

CSF3R T618I CSF3R T618I	Chronic Neutrophilic Leukemia Chronic Neutrophilic Leukemia	ruxolitinib Sensitive: C3 – Early Trials	ruxolitinib Sensitive: C3 – Early Trials
CSF3R S783 CSF3R S783	Chronic Neutrophilic Leukemia Chronic Neutrophilic Leukemia	dasatinib Sensitive: D – Preclinical	dasatinib Sensitive: D – Preclinical
CSF3R T618I CSF3R T618I	Chronic Neutrophilic Leukemia Chronic Neutrophilic Leukemia	dasatinib Resistant: D – Preclinical	dasatinib Resistant: D – Preclinical